FDA’s Gottlieb says AI ‘holds enormous promise for the future of medicine’

Michael Walter | | Radiology Business | Artificial Intelligence
scott gottlieb fda

The FDA is working to encourage the use of artificial intelligence (AI) technologies in healthcare, according the prepared remarks by the agency’s commissioner, Scott Gottlieb, MD, at Health Datapalooza in Washington, D.C.

“AI holds enormous promise for the future of medicine,” Gottlieb said in the remarks, as reported by CNBC.  “We're actively developing a new regulatory framework to promote innovation in this space, and support the use of AI-based technologies.”

Gottlieb added that the FDA expects the number of AI-based submissions to continue to rise, “starting with medical imaging devices,” as these technologies evolve.

Click below to read the full story from CNBC.

FDA moves to encourage A.I. in medicine, drug development

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Navigating the radiology workforce shortage: 6 potential solutions
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care
RSNA 2024 Program Chair Kate Hanneman highlights key trends in radiology
Do large language models help or hinder workflows related to radiology reports?
Hospital creates 'virtual reality technologist' role to support patients during interventional procedures

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.